Dr. Michael S. Remetz, MD

Dr. Remetz practices at Yale Medicine in New Haven, Connecticut.

Dr. Remetz's NPI, 1568450641, was assigned on October 12, 2005. Dr. Remetz graduated from Jefferson Medical College of Thomas Jefferson University in 1981. Dr. Remetz holds Connecticut license 027553.

Dr. Remetz's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Remetz's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Remetz is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Remetz to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Remetz practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Remetz's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Remetz is licensed in Connecticut.

CMS data shows 891 Medicare services from Dr. Remetz across 6 procedure codes in 2024, for 397 Medicare patients. Medicare paid $43,650 for them.

CMS counts 397 Medicare patients who saw Dr. Remetz in 2024. The largest group is 75 to 84, with 170 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Remetz's median patient age at 75, with 40% women.

In 2024, Dr. Remetz wrote 7,251 Medicare Part D claims for 777 patients. 86% of them were for generic drugs. CMS names the drug for 6,995 of them, across 55 drugs with 11 or more claims each, at $1,118,352 in total drug cost. In 2023, CMS named 6,222 claims across 51 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Remetz for performance year 2024, reported as part of a group. Dr. Remetz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Remetz as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Remetz, published from 2011 to 2015. 2012 was the busiest year, with 2. The most frequent topics are Stents. Dr. Remetz's most frequent co-authors are Michael W. Cleman, MD, Jeptha Pelham Curtis, MD and Ronak Bhimani.

Dmand AI links Dr. Remetz to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Hypertension and Vascular Diseases. Medtronic Vascular sponsors the most, 2.

CMS Open Payments shows 26 general payments to Dr. Remetz from 5 drug and device companies from 2016 to 2022. Travel and lodging make up the largest share, 54% of the total. Medtronic Vascular, Inc. paid the most, $2,548.

Dr. Remetz graduated from Jefferson Medical College of Thomas Jefferson University in 1981.